cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Complex roles of nicotinamide N-methyltransferase in cancer progression Targeting CD38-dependent NAD+ metabolism to
Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline: Cell Metabolism Nicotinamide N methyltransferase inhibition mimics and boosts exercise mediated improvements in muscle function in aged mice Scientific Reports Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome A systems approach to NAD+ restoration ScienceDirect
Pay in 4 interest-free payments of $6.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




